As part of their strategic plans for growth, Reacta Healthcare, based in Deeside North Wales, has made three senior appointments in the commercial, new product and people functions of the business. These new hires will support the company to bolster its commitment to the food allergy arena. The company produces challenge meals, which are […]
Category Archives: Press Releases
20
Sep
Sep
At Reacta Healthcare, we’re not just keen to support our existing workforce. We make it our mission to foster new talent and nurture the new generation entering the workforce. Our work experience placements give bright, enthusiastic young people a taste of working life in STEM and the pharmaceutical sector. Lucy Ollier is an A […]
08
Aug
Aug
Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents already held across Europe, Australia, Canada, Hong Kong, and the UK. The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation […]
14
Jul
Jul
Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market. Reacta Biotech (Reacta), which is based in Deeside, North Wales, produces clinical diagnostics kits for food allergy testing. The business improves the efficiency, accuracy and safety of food […]
19
May
May
Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic product within the next two years as global activity to treat peanut allergies accelerates.
News and Events, Press Releases
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans
21
Apr
Apr
We share relevant third party stories on our website. This release was written and issued by Reacta.